Company Filing History:
10 out of 3,685 
1 out of 3,580 
1 out of 1,309 
Years Active: 1997-2019
Title: The Innovative Contributions of Charles Malcolm Langevine
Introduction
Charles Malcolm Langevine is a notable inventor based in Brooklyn, NY, who has made significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Langevine's work focuses on developing compounds that have therapeutic applications in various medical conditions.
Latest Patents
Among his latest patents, Langevine has developed imidazopyridazine compounds that serve as modulators of IL-12, IL-23, and/or IFN alpha responses. These compounds are designed to act on Tyk-2, leading to signal transduction inhibition, which is crucial in managing immune responses. Another significant patent involves substituted tetrahydrocarbazole and carbazole carboxamide compounds. These compounds are disclosed as inhibitors of Bruton's tyrosine kinase (Btk) and are useful in treating autoimmune diseases and vascular diseases.
Career Highlights
Langevine has had a distinguished career, working with prominent companies such as Bristol-Myers Squibb Company and American Cyanamid Company. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Langevine has collaborated with notable colleagues, including Scott Hunter Watterson and Soo Sung Ko. These partnerships have facilitated the advancement of innovative solutions in the field of medicine.
Conclusion
Charles Malcolm Langevine's contributions to pharmaceutical innovations through his patents and collaborations highlight his significant impact on medical research and development. His work continues to influence therapeutic strategies for various diseases.